AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2007
Mar 5, 2007
35599_dirs_2007-03-05_76a349e7-26b1-4fee-96e5-747142aa7e8b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ADHEREX TECHNOLOGIES INC (AMEX:ADH)
CIK: 0001211583
Period of Report: 2007-02-21
Reporting Person: MURRAY D SCOTT (SVP, Gen Counsel & Corp Secty)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $.28 | 2014-02-28 | Common Stock (200000) | Direct | |
| Stock Options (Right to buy) | $.88 | 2012-12-14 | Common Stock (41600) | Direct | |
| Stock Options (Right to buy) | $1.2 | 2012-09-21 | Common Stock (24900) | Direct | |
| Stock Options (Right to buy) | $1.75 | 2010-02-12 | Common Stock (30000) | Direct | |
| Stock Options (Right to buy) | $1.95 | 2011-12-17 | Common Stock (18000) | Direct | |
| Stock Options (Right to buy) | $2.25 | 2010-12-30 | Common Stock (11970) | Direct | |
| Stock Options (Right to buy) | $2.45 | 2010-12-19 | Common Stock (10000) | Direct | |
| Stock Options (Right to buy) | $2.9 | 2011-05-21 | Common Stock (8000) | Direct |
Footnotes
F3: The options to which this note relates are subject to the following vesting schedule: (i) 15,000 shares vesting immediately and (ii) the remaining shares vesting in three (3) equal installments on the anniversary of the Grant Date reported above.
F1: The options to which this note relates are subject to vesting in three (3) installments with one-third vesting immediately and the remaining shares vesting on the first and second anniversary of the Grant Date reported above.
F2: The options to which this note relates vest in three (3) equal installments beginning on the date reported above.
F4: Exercise price for these options are in Canadian Dollars.